Positron Emission Tomography (PET) Scanners Market Growth Is Expected To See a growth of 5.1% by year 2031-end | Get Insights FMI
[181 Pages Report] The global positron emission tomography (PET) scanners market growth was valued at over US$ 1.2 Bn in 2021 and is expected to exhibit a CAGR of close to 5.1% over the forecast period.
The concept of PET as a nuclear medicine imaging technology was established in early 1970s. Ever since the technology has evolved into routine clinical imaging modality, revolutionizing the process of diseases diagnosis and management into more effective fashion.
Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1333
PET is a molecular imaging technology that detects the concentration and pharmacokinetics of radiotracer molecules that are labelled with radioisotopes. This helps to diagnose and determine the severity of a various diseases such as neurological disorders, cardiovascular disorders, cancer, gastrointestinal and various others.
Based on the operational and geometrical capabilities of PET scanners, the systems are classified as full ring PET systems and partial ring PET systems. Advancements in technological performance of these systems are always associated with higher cost, limiting its widespread utilization in clinical PET imaging.
Rising prevalence of chronic disorders such as cancer and cardiovascular disorders, coupled with greater awareness towards physical wellbeing and limitations of conventional PET scanner is spurring demand for effective diagnostic techniques, thereby augmenting growth of the market.
PET scanners have continued to improve image quality and performance over the last few years. Technological improvements such as managing dose, reduced imaging time and enhanced lesion detectability have increased PET’s functionality, thus making it easier to interpret and diagnose various life-threatening disorders.
Speak to our Research Expert @ https://www.futuremarketinsights.com/ask-regional/rep-gb-1333
Key Market Segments Covered
- Full-ring PET scanner
- Partial-ring PET scanner
By Detector Type:
- Bismuth Germanium Oxide (BGO)
- Lutetium Oxyorthosilicate (LSO)
- Gadolinium Oxyorthosilicate (GSO)
- Lutetium Fine Silicate (LFS)
- Lutetium Yttrium Orthosilicate
By End User:
- Diagnostic Centers
- PET Centers
- Research Institute
By product, full-ring PET scanner is expected to hold over 86.2% of the total market share by 2031.
Sales in the oncology segment accounted for over 85.2% of market share in 2020, owing to the increasing incidence of chronic diseases and cancer.
Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1333
Based on detector type, demand in the lutetium oxyorthosilicate (LSO) segment to held over 37.3% of market share in 2020.
Hospitals dominate end user segment with a share of around 34.9% in 2020 due to increasing patient inflow after COVID-19 outbreak.
“Ongoing technological advancements in PET scanners, copled with increasing applications in diagnostic centers and research institutes will propel the growth of the market in the forthcoming years” says a FMI analyst.
Who is winning?
Acquisitions, mergers, expansion, and product launches are the key strategies adopted by manufacturers to increase consumer base in different geographies. For instance:
In January 2020, Koninklijke Philips N.V. introduced its advanced solutions called Vereos Digital PET/CT (world’s first and only fully digital, clinically proven, PET/CT solution), an AI-powered solution for precision diagnosis at IRIA 2020.
Top Related Reports Healthcare Market Insights
General Anesthesia Drugs Market : is expected to enjoy a valuation of US$ 4.7 Bn by the end of the year 2022, and further expand at a CAGR rate of 3.4% to reach a valuation of US$ 6.7 Bn by the year 2032.
Injectable Drugs Market : is expected to reach US$ 531.8 Bn in 2022. Sales in the market will increase at a CAGR of 5.8%, reaching US$ 937.0 Bn by 2032.
Critical Care Patient Monitoring Products Market : is expected to grow at a CAGR of 8.6%.
Cardiac Biomarker Diagnostic Test Kits Market : is projected to expand at 5.1% CAGR over the forecast period, from 2022 to 2028.
Cardiac Assist Devices Market : is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Bn by 2031.
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
For Sales Enquiries: firstname.lastname@example.org
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs